Apoptotic, Regenerative, And Immune-Related Signaling in Human Islets from Type 2 Diabetes Individuals
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Islet dysfunction is a primary cause of developing type 2 diabetes mellitus (T2DM). Events leading to islet failure are still poorly defined due to the complexity of the disease and scarcity of human T2DM islets. The aim of the present study was to identify cellular mechanisms involved in the T2DM pathophysiology by protein profiling islets obtained from T2DM individuals and age- and weight-matched controls using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry and surface enhanced laser desorption/ionization time-of-flight mass spectrometry. In T2DM islets, multiple differentially expressed proteins correlated with insulin secretion. When these T2DM islet proteins were analyzed for differential pathway activation, three of the five most activated pathways were pathways of cell arrest and apoptosis (p53, caspase, stress-activated), one represented immune-response (Fas), and the most activated pathway was connected with proliferation and regeneration (E2F). Among the inactivated pathways, three out of five were pathways of proliferation and regeneration (insulin, PRL, PDGF). The present study is the first to report differential activation of specific pathways during T2DM islet deterioration. The information about alterations in pathway signaling patterns may open new ways to develop strategies aimed at restoring islet cell function and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior studies correlated increased PDGFR and EZH2 expression in human endocrine neoplasias38, and disrupted PDGF signalling in β-cells of humans with type 2 diabetes39.”
From PDGF signalling controls age-dependent proliferation in pancreatic β-cells (2011) · cites this paper as [39]
Citations
Cites
1 retracted
Maedler, K., Schumann, D. M., Sauter, N., Ellingsgaard, H., Bosco, D., Baertschiger, R., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 156
Retractedβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Schulze, M. B. (2004) · JAMA · doi:10.1001/jama.292.8.927 · Cited by 1,639
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312
Kulkarni, R. N., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Del Guerra, S., Lupi, R., Marselli, L., Masini, M., Bugliani, M., Sbrana, S., Torri, S., Pollera, M., Boggi, U., Mosca, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.727 · Cited by 466
Self-citationGlucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Maedler, K., Spinas, G. A., Lehmann, R., Sergeev, P., Weber, M., Fontana, A., Kaiser, N., & Donath, M. Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1683 · Cited by 367
Glucose and Tolbutamide Induce Apoptosis in Pancreatic β-Cells
Efanova, I. B., Zaitsev, S. V., Zhivotovsky, B., Köhler, M., Efendić, S., Orrenius, S., & Berggren, P.-O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33501 · Cited by 364
Marchetti, P., Del Guerra, S., Marselli, L., Lupi, R., Masini, M., Pollera, M., Bugliani, M., Boggi, U., Vistoli, F., Mosca, F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0150 · Cited by 338
Self-citationBöni-Schnetzler, M., Thorne, J., Parnaud, G., Marselli, L., Ehses, J. A., Kerr-Conte, J., Pattou, F., Halban, P. A., Weir, G. C., & Donath, M. Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0396 · Cited by 320
To die or not to die: how does p53 decide?
Slee, E. A., O'Connor, D. J., & Lu, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207516 · Cited by 278
Altered function of insulin receptor substrate-1–deficient mouse islets and cultured β-cell lines
Kulkarni, R. N., Winnay, J. N., Daniels, M., Brüning, J. C., Flier, S. N., Hanahan, D., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8339 · Cited by 268
Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)
Wrede, C. E., Dickson, L. M., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208756200 · Cited by 246
Ostenson, C.-G., Gaisano, H., Sheu, L., Tibell, A., & Bartfai, T. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db04-1575 · Cited by 232
Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell
Cozar-Castellano, I., Fiaschi-Taesch, N., Bigatel, T. A., Takane, K. K., Garcia-Ocaña, A., Vasavada, R., & Stewart, A. F. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0004 · Cited by 198
The Identification of Potential Factors Associated with the Development of Type 2 Diabetes
Lu, H., Yang, Y., Allister, E. M., Wijesekara, N., & Wheeler, M. B. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700478-mcp200 · Cited by 193
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome
Johnson, J. D., Bernal-Mizrachi, E., Alejandro, E. U., Han, Z., Kalynyak, T. B., Li, H., Beith, J. L., Gross, J., Warnock, G. L., Townsend, R. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604208103 · Cited by 188
Meier, J. J., Lin, J. C., Butler, A. E., Galasso, R., Martinez, D. S., & Butler, P. C. (2006) · Diabetologia · doi:10.1007/s00125-006-0308-2 · Cited by 181
Critical Reduction in β-Cell Mass Results in Two Distinct Outcomes over Time
Laybutt, D. R., Glandt, M., Xu, G., Ahn, Y. B., Trivedi, N., Bonner-Weir, S., & Weir, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210581200 · Cited by 156
Nielsen, M. L., Savitski, M. M., & Zubarev, R. A. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t400022-mcp200 · Cited by 139
Self-citationAckermann Misfeldt, A., Costa, R. H., & Gannon, M. (2008) · Diabetes · doi:10.2337/db08-0878 · Cited by 114
Role of caspases in the regulation of apoptotic pancreatic islet beta‐cells death
Hui, H., Dotta, F., Mario, U. D., & Perfetti, R. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20021 · Cited by 104
Doğusan, Z., García, M., Flamez, D., Alexopoulou, L., Goldman, M., Gysemans, C. A., Mathieu, C., Libert, C., Eizirik, D. L., & Rasschaert, J. (2008) · Diabetes · doi:10.2337/db07-0844 · Cited by 102
Paraskevas, S., Aikin, R. A., Maysinger, D., Lakey, J. R. T., Cavanagh, T. J., Hering, B. J., Wang, R., & Rosenberg, L. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00882-0 · Cited by 93
Blandino-Rosano, M., Perez-Arana, G., Mellado-Gil, J. M., Segundo, C., & Aguilar-Diosdado, M. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0154 · Cited by 82
Sanchez, J.-C., Converset, V., Nolan, A., Schmid, G., Wang, S., Heller, M., Sennitt, M. V., Hochstrasser, D. F., & Cawthorne, M. A. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200033-mcp200 · Cited by 77
Ahmed, M., Forsberg, J., & Bergsten, P. (2005) · Journal of Proteome Research · doi:10.1021/pr050024a · Cited by 74
Self-citationRamström, M., Ivonin, I. A., Johansson, A., Askmark, H., Markides, K. E., Zubarev, R. A., Håkansson, P., Aquilonius, S., & Bergquist, J. (2004) · PROTEOMICS · doi:10.1002/pmic.200400871 · Cited by 70
Self-citationEGF receptor in pancreatic β-cell mass regulation
Miettinen, P. J., Ormio, P., Hakonen, E. T., Banerjee, M., & Otonkoski, T. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360280 · Cited by 66
Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet β-Cells
Zhang, S., Liu, H., Yu, H., & Cooper, G. J. S. (2008) · Diabetes · doi:10.2337/db07-0849 · Cited by 64
Characterization of the Human Pancreatic Islet Proteome by Two-Dimensional LC/MS/MS
Metz, T., Jacobs, J., Gritsenko, M. A., Fontès, G., Qian, W., Camp, D., Poitout, V., & Smith, R. D. (2006) · Journal of Proteome Research · doi:10.1021/pr060322n · Cited by 62
Ahmed, M., & Bergsten, P. (2005) · Diabetologia · doi:10.1007/s00125-004-1661-7 · Cited by 62
Self-citationBrun, T., He, K. H. H., Lupi, R., Boehm, B. O., Wojtusciszyn, A., Sauter, N. S., Donath, M. Y., Marchetti, P., Maedler, K., & Gauthier, B. R. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm325 · Cited by 62
Self-citationGao, W., Ferguson, G., Connell, P., Walshe, T. E., Murphy, R. P., Birney, Y. A., O'Brien, C. J., & Cahill, P. A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.12.006 · Cited by 55
TNF-Related Apoptosis-Inducing Ligand Death Pathway-Mediated Human Beta-Cell Destruction
Ou, D., Metzger, D. L., Wang, X., Huang, J., Pozzilli, P., & Tingle, A. J. (2002) · Diabetologia · doi:10.1007/s00125-002-0926-2 · Cited by 51
Effect of short‐term culture on functional and stress‐related parameters in isolated human islets
Ihm, S., Matsumoto, I., Zhang, H. J., Ansite, J., & Hering, B. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00769.x · Cited by 49
Genome-wide association study for type 2 diabetes: clinical applications
Lyssenko, V., & Groop, L. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832923af · Cited by 42
Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes
Lin, J.-M., Fabregat, M. E., Gomis, R., & Bergsten, P. (2002) · Diabetes · doi:10.2337/diabetes.51.4.988 · Cited by 42
Self-citationIdentification of dominant signaling pathways from proteomics expression data
Zubarev, R. A., Nielsen, M. L., Fung, E., Savitski, M. M., Kel-Margoulis, O. V., Wingender, E., & Kel, A. E. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.01.004 · Cited by 39
Self-citationTissue Culture Reduces la Antigen-bearing Cells in Rat Islets and Prolongs Islet Allograft Survival
Rabinovitch, A., Alejandro, R., Noel, J., Brunschwig, J. P., & Ryan, U. S. (1982) · Diabetes · doi:10.2337/diab.31.4.s48 · Cited by 37
Nyblom, H. K., Thörn, K., Ahmed, M., & Bergsten, P. (2006) · PROTEOMICS · doi:10.1002/pmic.200600137 · Cited by 35
Self-citationPan, Q., Li, W. H., Wang, H., Sun, Q., Xiao, X., Brock, B., & Schmitz, O. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1234043 · Cited by 34
Yu, D. H., Mace, K. A., Hansen, S. L., Boudreau, N. J., & Young, D. M. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00274.x · Cited by 32
Ortsäter, H., Sundsten, T., Lin, J., & Bergsten, P. (2007) · PROTEOMICS · doi:10.1002/pmic.200601019 · Cited by 18
Self-citationProtein profiling of pancreatic islets
Ortsäter, H., & Bergsten, P. (2006) · Expert Review of Proteomics · doi:10.1586/14789450.3.6.665 · Cited by 18
Self-citation
Cited by
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
“For instance, quantitative protein profiling of islets from T2D and non-diabetic individuals revealed differential expression in twenty major pathways, which correlated with their insulin secretion profile [151].”
BackgroundToperoff, G., Aran, D., Kark, J. D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr472 · Cited by 349
“Similar to USF1/2, MYCN and E2F family members bind their target sequences in a methylation-dependent manner (30,31), and might participate in T2DM-related pathways (32).”
BackgroundPDGF signalling controls age-dependent proliferation in pancreatic β-cells
Chen, H., Gu, X., Liu, Y., Wang, J., Wirt, S. E., Bottino, R., Schorle, H., Sage, J., & Kim, S. K. (2011) · Nature · doi:10.1038/nature10502 · Cited by 278
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.007 · Cited by 141
“Analysis of islets from T2D patients previously identified an increased expression of proteins in the p53 pathway (Nyblom et al., 2009) and increased mRNA expression of the p53 target p21 (Marselli et al.”
BackgroundFong, T. T., Lok, C., Chung, C. Y., Fung, Y. M. E., Chow, P., Wan, P., & Che, C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602814 · Cited by 139
Metadata
- Authors
- Nyblom, H. K., Bugliani, M., Fung, E., Boggi, U., Zubarev, R., Marchetti, P., & Bergsten, P.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Zubarev, Roman
- Bergsten, Peter
- Venue
- Journal of Proteome Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 5650-5656
- ISSN
- 1535-3893 (ISSN-L)
- 1535-3907
- OpenAlex
- W2003385277
- Cited by
- 33
- References
- 49
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 3 · 2013: 3 · 2012: 4
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Proteome Research (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, pancreatic islets, islet dysfunction, apoptosis, cell cycle arrest, islet regeneration, immune signaling, p53, caspases, Fas, E2F transcription factors, insulin secretion, proteomic profiling, pathway activation
- MeSH terms
- Insulin Secretion, Aged, Diabetes Mellitus, Type 2, Female, Gene Expression Regulation, Humans, Immunity, Insulin, Islets of Langerhans, Male, Middle Aged, Proteins, Regeneration, Signal Transduction, Case-Control Studies, Apoptosis, Proteomics, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.